Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Isao Sakita"'
Autor:
Shintaro Takao, Seishi Kono, Masaru Miyashita, Muneharu Konishi, Ikuo Kokufu, Hirofumi Suwa, Koushiro Kitatsuji, Yutaka Konishi, Isao Sakita, Masayuki Nishino, K Yamagami, Hidefumi Nishikawa, Masahiro Kishimoto, Keisuke Miyauchi, Takashi Matsumoto, Toshitaka Okuno, Akihiro Miya, Koushi Oh, Masashi Baba, Kazuyuki Wakita, Toshiharu Hidaka, Takashi Hashimoto, Yoko Sakoda, Shigetoshi Ichii, Yasuo Miyoshi, Junya Minohata, Yuichiro Kikawa, Chiyomi Egawa
Publikováno v:
Cancer Research. 80:P5-12
Background Five-year adjuvant treatment with aromatase inhibitors is a standard treatment for postmenopausal women with estrogen receptor-positive breast cancer. However, aromatase inhibitor-related adverse events, including joint and vasomotor sympt
Publikováno v:
Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 29:119-123
Publikováno v:
[Nihon koshu eisei zasshi] Japanese journal of public health. 69(2)
Objective This study aimed to promote the application of mammography (MMG) screening without performing a clinical breast examination (CBE). It examined population-based screening data, including history taking findings, to elucidate the status of br
Autor:
Masahiro Kishimoto, Masaru Miyashita, Masayuki Nishino, Takashi Matsumoto, Yutaka Konishi, Shigetoshi Ichii, Toshiharu Hidaka, Masashi Baba, Takashi Hashimoto, Muneharu Konishi, Hidefumi Nishikawa, Yoko Sakoda, Ikuo Kokufu, Shintaro Takao, Akihiro Miya, Koushiro Kitatsuji, Isao Sakita, Junya Minohata, Kazuyuki Wakita, Koushi Oh, Kazuhiko Yamagami, Yuichiro Kikawa, Toshitaka Okuno, Seishi Kono, Keisuke Miyauchi, Kouhei Akazawa, Kaori Tane, Chiyomi Egawa, Hirofumi Suwa, Yasuo Miyoshi
Publikováno v:
Breast Cancer. 24:528-534
Adverse events related to endocrine therapies have a major impact not only on patients’ quality of life but also on treatment discontinuation. Although vasomotor symptoms induced by aromatase inhibitors are frequently recognized, risk factors, espe
Autor:
Toyomasa Katagiri, Hiromi Ozawa, Ayako Yanai, Isao Sakita, Takuya Hatada, Tomoko Higuchi, Arisa Nishimukai, Yasuo Miyoshi, Yoshimasa Miyagawa, Keiko Murase, Yuichi Takatsuka, Michiko Imamura
Publikováno v:
Breast Cancer Research and Treatment. 154:521-531
It is speculated that adjuvant use of bisphosphonate reduces recurrence in breast cancer patients through suppression of bone resorption. To determine the prognostic impact of bone resorption markers, we investigated serum levels of the pyridinoline
Autor:
Ikuo Kokufu, Toshiharu Hidaka, Hirofumi Suwa, Seishi Kono, Masashi Baba, Koushiro Kitatsuji, Takashi Matsumoto, Yoko Sakoda, Isao Sakita, Hidefumi Nishikawa, Muneharu Konishi, Shigetoshi Ichii, Toshitaka Okuno, Akihiro Miya, Junya Minohata, Chiyomi Egawa, Koushi Oh, Kazuyuki Wakita, Yuichiro Kikawa, Masahiro Kishimoto, Yasuo Miyoshi, Keisuke Miyauchi, Kazuhiko Yamagami, Takashi Hashimoto, Yutaka Konishi, Masayuki Nishino, Shintaro Takao, Masaru Miyashita
Publikováno v:
Cancer Research. 75:P1-12
Background: Adjuvant five-year treatment with aromatase inhibitors is standard for postmenopausal women with estrogen receptor positive breast cancer. However, aromatase inhibitor-related adverse events including joint symptoms and vasomotor symptoms
Autor:
Takayoshi Fujimoto, Chikara Ebisui, Nariaki Fukuchi, Masaki Tsujie, Isao Sakita, Tetsuya Yoshida
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 68:552-556
眼窩転移を生じた乳癌3症例を経験した. 1例は乳癌の初発再発として眼窩転移を生じ, 腫瘍摘出術の結果, 失明・兎眼性角膜炎というもっともQOLを損なう結果となった. 2例は早期に診断し
Autor:
Yutaka Konishi, Masayuki Nishino, Junya Minohata, Masashi Baba, Takashi Hashimoto, Takashi Matsumoto, K. Hirokaga, Yuichiro Kikawa, Koushi Oh, Shintaro Takao, Toshitaka Okuno, Yasuo Miyoshi, Akihiro Miya, Hidefumi Nishikawa, Ikuo Kokufu, Hirofumi Suwa, Kazuyuki Wakita, Yoko Sakoda, Toshiharu Hidaka, Shigetoshi Ichii, Isao Sakita, Masaru Miyashita, Kazuhiko Yamagami, Chiyomi Egawa, Koushiro Kitatsuji, Masao Mitsunobu, Seishi Kono, Keisuke Miyauchi, Muneharu Konishi
Publikováno v:
International journal of clinical oncology. 21(2)
Endocrine treatment-related adverse events have a strong impact on patients’ quality of life and sometimes result in treatment discontinuation. Since joint symptoms are the most frequently recognized side effect of aromatase inhibitors, evaluation
Autor:
Nariaki Matsuura, Lloyd J. Old, Yasuhiro Tamaki, Morito Monden, Sacha Gnjatic, Yuji Noguchi, Elisabeth Stockert, Masayoshi Yasui, Yurika Sugita, Shoichiro Fujita, Yao-Tseng Chen, Matthew J. Scanlan, Toshiro Ono, Barbara Williamson, Achim A. Jungbluth, Shinzaburo Noguchi, Yasuo Miyoshi, Tetsuya Nakata, Masae Yamaguchi, Shuichiro Sato, Hisashi Wada, Eiichi Nakayama, Isao Sakita
Publikováno v:
Cancer Research. 64:2199-2204
NY-ESO-1 is a cancer/testis antigen expressed in normal adult tissues solely in the testicular germ cells of normal adults and in various cancers. It induces specific humoral and cellular immunity in patients with NY-ESO-1-expressing cancer. The aim
Autor:
Yoshihiro Nishida, Isao Sakita, Hirohito Hayashida, Tetsuya Yoshida, Kinya Sugimoto, Junzaburo Takemasa
Publikováno v:
Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 12:58-63